EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992

Verfasser / Beitragende:
[James Spicer, Sarah Rudman]
Ort, Verlag, Jahr:
2010
Enthalten in:
Targeted Oncology, 5/4(2010-12-01), 245-255
Format:
Artikel (online)
ID: 445169079